SLC2A8 and fatty liver disease: Germline, whole-body GLUT8-deficient mice, and mice treated with GLUT8 gene-silencing oligonucleotides exhibit increased calorie expenditure, increased hepatocyte fasting-like signaling through the PPARα pathway, and protection from hepatic steatosis in diet-induced obese models.7